Welcome to our dedicated page for Baker Hughes Co SEC filings (Ticker: BKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Baker Hughes Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Baker Hughes Co's regulatory disclosures and financial reporting.
Baker Hughes Company provided an update on its planned acquisition of Chart Industries, Inc. under their previously announced Merger Agreement. Baker Hughes and Chart are in discussions with the European Commission about potential commitments to secure Phase I antitrust clearance.
The companies state that any proposed commitments are not expected to change the commercial rationale or expected benefits of the merger. Based on the European Commission’s review timetable and customary closing conditions, Baker Hughes continues to expect the merger to close in July 2026.
Baker Hughes Co EVP and CFO Moghal Ahmed Farhan reported net sales of 23,392 shares of Class A Common Stock in open-market transactions. On June 15, 2026, 20,000 directly held shares were sold at $62.38 per share, leaving 20,980 directly owned shares. An additional 3,392 indirectly held shares owned by his spouse were sold at $62.38 per share, leaving no remaining indirect holdings. Both the direct and spouse transactions were executed under pre-established Rule 10b5-1 trading plans adopted on March 13, 2026.
Baker Hughes Chairman, President and CEO Lorenzo Simonelli reported an exercise-and-sell transaction in Class A Common Stock. He sold 181,411 shares in an open-market sale at a weighted average price of $63.36 per share pursuant to a Rule 10b5-1 trading plan.
Simonelli also exercised stock options to acquire 99,911 shares at an exercise price of $35.55 per share. Following the reported sale, he directly holds 784,944 shares of Baker Hughes Class A Common Stock.
BKR files a Form 144 notice to sell 20,000 shares of Class A common stock. The filing identifies Fidelity Brokerage Services LLC as the broker and an aggregate sale amount of $1,247,600.00 on the NASDAQ.
The excerpt lists restricted stock vesting events associated with the shares: 552 shares vesting 01/30/2026, 3,309 shares vesting 02/01/2026, 4,065 shares vesting 02/24/2026, and 12,074 shares vesting 03/08/2026. The entries are labeled as Restricted Stock Vesting and Compensation.
BKR filed a Form 144 notice reporting proposed sales of Class A shares by an issuer-related holder. The excerpt lists multiple restricted stock vesting events totaling specific share amounts on entries and a stock option exercise of 99,911 shares on 06/12/2026. The filing is a notice of intended resale; timing and purchaser details are not provided in the excerpt.
Baker Hughes executive Rebecca L. Charlton, SVP, Controller & CAO, reported a combination of RSU vesting, tax withholding, and an open-market sale of Class A Common Stock.
On June 1, 2026, 11,651 restricted stock units were exercised into the same number of common shares as the final installment of a June 1, 2023 grant. In connection with this vesting, 4,585 shares were disposed of to cover tax obligations.
On June 3, 2026, Charlton sold 5,088 shares in an open-market transaction at an average price of $64.22 per share. The filing notes this sale was made pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026. After these transactions, Charlton directly holds 15,997 shares of Baker Hughes Class A Common Stock.
Baker Hughes Co executive James E. Apostolides, Chief Infra & Performance Officer, reported an open-market sale of company stock. On May 19, 2026, he sold 12,261 shares of Class A Common Stock at $66.42 per share in a transaction reported as a sale. This trade was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 10, 2025. Following the sale, Apostolides directly holds 15,449 shares of Baker Hughes Co stock.
Dumais Michael R reported acquisition or exercise transactions in this Form 4 filing.
Baker Hughes Co director Michael R. Dumais received a grant of 2,749 Deferred Stock Units on Class A Common Stock. Each unit represents the right to receive one share of Class A Common Stock without payment, according to the footnotes.
The Deferred Stock Units vested immediately on the grant date and will be settled in shares within 30 days after Dumais’ retirement. This is a compensation-related equity award, not an open-market purchase or sale, and leaves Dumais with 2,749 Deferred Stock Units reported as directly held.